Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

22.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
22.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2.

NPJ vaccines·2026
Same author

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Nature communications·2026
Same author

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent.

The Journal of general virology·2026
Same author

B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cure.

bioRxiv : the preprint server for biology·2025
Same author

Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2.

bioRxiv : the preprint server for biology·2025
Same author

scFPC-DE: Robust Differential Expression Analysis Along Single Cell Trajectories via Functional Principal Component Analysis.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Nov 3, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.4K

From Structural Studies to HCV Vaccine Design.

Itai Yechezkel1, Mansun Law2, Netanel Tzarum1

  • 1Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Faculty of Mathematics & Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Viruses
|June 2, 2021
PubMed
Summary

Developing a universal Hepatitis C virus (HCV) vaccine requires understanding how neutralizing antibodies target HCV envelope glycoproteins. Structural studies reveal key epitopes for designing effective cross-genotype vaccine antigens to combat HCV infection.

Keywords:
E1E1E2 complexE2VH1-69envelope glycoproteinshepatitis C virus (HCV)neutralization faceneutralizing antibodiesstructural studiesvaccine design

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K

Related Experiment Videos

Last Updated: Nov 3, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.4K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • Hepatitis C virus (HCV) remains a global health challenge despite antiviral advances.
  • An effective cross-genotype vaccine is crucial for HCV elimination.
  • Previous vaccine trials failed due to inadequate cross-reactive immune responses.

Purpose of the Study:

  • To summarize recent structural studies of HCV envelope glycoproteins and their interactions with neutralizing antibodies (nAbs).
  • To elucidate the molecular basis of nAb recognition for improved vaccine antigen design.
  • To provide insights for developing a potent, cross-neutralizing HCV vaccine.

Main Methods:

  • Review of recent structural studies on HCV E1 and E2 envelope glycoproteins.
  • Analysis of structural data from HCV envelope-neutralizing antibody complexes.
  • Examination of epitope mapping and conformational plasticity of HCV envelope proteins.

Main Results:

  • Structural insights define key neutralization epitopes on HCV envelope glycoproteins.
  • Understanding conformational flexibility of envelope proteins is critical for nAb binding.
  • Recent structural data enhances comprehension of immune recognition mechanisms against HCV.

Conclusions:

  • Molecular-level understanding of HCV envelope-nAb interactions is essential for rational vaccine design.
  • Targeting conserved epitopes identified through structural studies can improve vaccine efficacy.
  • Advances in structural biology pave the way for developing effective cross-genotype HCV vaccines.